Literature DB >> 29443187

Movement disorders and psychiatry: Five new things.

Gemma Cummins1, Michael Zandi1, Roger A Barker1.   

Abstract

In this article we report recent interesting diagnostic and therapeutic advances in a diverse range of movement disorders with associated psychiatric comorbidity. Areas discussed include social cognition in Huntington disease, neuroimaging of functional movement disorders, treatment of psychosis in Parkinson disease, new advances in autoimmune disease, and management of Tourette syndrome.

Entities:  

Year:  2015        PMID: 29443187      PMCID: PMC5764446          DOI: 10.1212/CPJ.0000000000000113

Source DB:  PubMed          Journal:  Neurol Clin Pract        ISSN: 2163-0402


  18 in total

Review 1.  What patients with gilles de la tourette syndrome should be treated with deep brain stimulation and what is the best target?

Authors:  John Carlo Pansaon Piedad; Hugh Edward Rickards; Andrea Eugenio Cavanna
Journal:  Neurosurgery       Date:  2012-07       Impact factor: 4.654

Review 2.  Autoantibodies associated with diseases of the CNS: new developments and future challenges.

Authors:  Angela Vincent; Christian G Bien; Sarosh R Irani; Patrick Waters
Journal:  Lancet Neurol       Date:  2011-08       Impact factor: 44.182

3.  Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study.

Authors:  Maarten J Titulaer; Lindsey McCracken; Iñigo Gabilondo; Thaís Armangué; Carol Glaser; Takahiro Iizuka; Lawrence S Honig; Susanne M Benseler; Izumi Kawachi; Eugenia Martinez-Hernandez; Esther Aguilar; Núria Gresa-Arribas; Nicole Ryan-Florance; Abiguei Torrents; Albert Saiz; Myrna R Rosenfeld; Rita Balice-Gordon; Francesc Graus; Josep Dalmau
Journal:  Lancet Neurol       Date:  2013-01-03       Impact factor: 44.182

4.  Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders.

Authors:  Russell C Dale; Vera Merheb; Sekhar Pillai; Dongwei Wang; Laurence Cantrill; Tanya K Murphy; Hilla Ben-Pazi; Sophia Varadkar; Tim D Aumann; Malcolm K Horne; Andrew J Church; Thomas Fath; Fabienne Brilot
Journal:  Brain       Date:  2012-10-11       Impact factor: 13.501

Review 5.  Social cognition in neurodegenerative disorders: a systematic review.

Authors:  Marwa Elamin; Niall Pender; Orla Hardiman; S Abrahams
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-08-06       Impact factor: 10.154

6.  The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years.

Authors:  Mariese A Hely; Wayne G J Reid; Michael A Adena; Glenda M Halliday; John G L Morris
Journal:  Mov Disord       Date:  2008-04-30       Impact factor: 10.338

7.  Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.

Authors:  Sarah J Tabrizi; Rachael I Scahill; Gail Owen; Alexandra Durr; Blair R Leavitt; Raymund A Roos; Beth Borowsky; Bernhard Landwehrmeyer; Chris Frost; Hans Johnson; David Craufurd; Ralf Reilmann; Julie C Stout; Douglas R Langbehn
Journal:  Lancet Neurol       Date:  2013-05-09       Impact factor: 44.182

Review 8.  The psychopathological spectrum of Gilles de la Tourette syndrome.

Authors:  Andrea E Cavanna; Hugh Rickards
Journal:  Neurosci Biobehav Rev       Date:  2012-11-03       Impact factor: 8.989

9.  Disease-relevant autoantibodies in first episode schizophrenia.

Authors:  Michael S Zandi; Sarosh R Irani; Bethan Lang; Patrick Waters; Peter B Jones; Peter McKenna; Alasdair J Coles; Angela Vincent; Belinda R Lennox
Journal:  J Neurol       Date:  2010-10-26       Impact factor: 4.849

Review 10.  Imaging psychogenic movement disorders.

Authors:  Arpan R Mehta; James B Rowe; Anette E Schrag
Journal:  Curr Neurol Neurosci Rep       Date:  2013-11       Impact factor: 5.081

View more
  2 in total

1.  Frontostriatal circuitry as a target for fMRI-based neurofeedback interventions: A systematic review.

Authors:  Linda Orth; Johanna Meeh; Ruben C Gur; Irene Neuner; Pegah Sarkheil
Journal:  Front Hum Neurosci       Date:  2022-08-24       Impact factor: 3.473

2.  A Gain-of-Function Variant in Dopamine D2 Receptor and Progressive Chorea and Dystonia Phenotype.

Authors:  Marlous C M van der Weijden; Dayana Rodriguez-Contreras; Cathérine C S Delnooz; Brooks G Robinson; Alec F Condon; Michelle L Kielhold; Gilles N Stormezand; Kai Yu Ma; Claudia Dufke; John T Williams; Kim A Neve; Marina A J Tijssen; Dineke S Verbeek
Journal:  Mov Disord       Date:  2020-11-16       Impact factor: 10.338

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.